Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter Ended 30.06.2022.
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve Approval of unaudited Financial Results for quarter ended 30.06.2022. Ortin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 Ortin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nitesh Kumar SharmaDesignation :- Company Secretary and Compliance Officer Ortin Laboratories Ltd - 539287 - Closure of Trading Window
Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015 Ortin Laboratories Ltd - 539287 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31.03.2022
Disclosure of Related Party Transactions under Regulation 23(9) of SEBI (LODR) Regulations, 2015 for the half year ended 31.03.2022 Ortin Laboratories Ltd - 539287 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of audited financial results for quarter and year ended 31.03.2022 Ortin Laboratories Ltd - 539287 - Audited Financial Results For Quarter And Financial Year Ended 31St March, 2022.
Audited Financial Results for Quarter and Financial Year ended 31st March, 2022 Ortin Laboratories Ltd - 539287 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31.03.2022 Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended 31.03.2022
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve audited financial results for the quarter and year ended 31.03.2022